American Heart Journal
Volume 146, Issue 2 , Pages 210-212 , August 2003

Subclinical diabetes mellitus: is it really“sub-clinical”?

  • Mary E. Keebler, MD

      Affiliations

    • Department of Internal Medicine, Massachusetts General Hospital, Boston, Mass, USA
    • ,
  • Darren K. McGuire, MD, MHSc

      Affiliations

    • Donald W. Reynolds Cardiovascular Research Center, Department of Medicine, University of Texas Southwestern Medical Center at Dallas, Tex, USA
    • Corresponding Author InformationReprint requests: Reprints not available from the authors., Dallas, Tex USA

References 

  1. Mokdad AH, Bowman BA, Ford ES, et al.  The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–2000
  2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025 (prevalence, numerical estimates, and projections). Diabetes Care. 1998;21:1414–1431
  3. Saydah SH, Loria CM, Eberhardt MS, et al.  Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care. 2001;24:447–453
  4. Norhammar A, Tenerz A, Nilsson G, et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus (a prospective study). Lancet. 2002;359:2140–2144
  5. Taubert G, Winkelman BR, Schleiffer T, et al. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J. In press 2002
  6. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  7. World Heath Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: report of a WHO consultation: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999;
  8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  9. Muhlestein JB, Anderson JL, Horne BD, et al.  Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003;146:351–358
  10. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Tenn Med. 2000;93:419–429
  11. Gibbons RJ, Chatterjee K, Daley J, et al.  ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina (a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)). J Am Coll Cardiol. 1999;33:2092–2197

PII: S0002-8703(03)00236-9

doi: 10.1016/S0002-8703(03)00236-9

American Heart Journal
Volume 146, Issue 2 , Pages 210-212 , August 2003

Article Tools